Veterinary Medicines

Ursocyclin-Schaumstäbe 1,2 g Tabletten zur intrauterinen Anwendung für Rinder (Kühe) und Schweine (Zuchtsauen)

Not authorised
  • Oxytetracycline hydrochloride
Download as PDF

Product identification

Medicine name:
Ursocyclin-Schaumstäbe 1,2 g Tabletten zur intrauterinen Anwendung für Rinder (Kühe) und Schweine (Zuchtsauen)
Active substance:
  • Oxytetracycline hydrochloride
Target species:
  • Cattle (dairy cow)
  • Pig (sow for reproduction)
Route of administration:
  • Intrauterine use

Product details

Active substance and strength:
  • Oxytetracycline hydrochloride
    1.20
    gram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Intrauterine tablet
Withdrawal period by route of administration:
  • Intrauterine use
    • Cattle (dairy cow)
      • Milk
        7
        day
      • Meat and offal
        8
        day
    • Pig (sow for reproduction)
      • Meat and offal
        8
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG51AA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Serumwerk Bernburg AG
Marketing authorisation date:
Manufacturing sites for batch release:
  • Serumwerk Bernburg AG
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 3100309.00.00
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 21/12/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."